Traditional drug discovery uses semi-automated or manual curation of retrosythetic pathways to synthesize a target molecule. However, manual retrosynthetic analysis can be time-consuming and requires substantial expertise. The need to swiftly generate and assess diverse synthesis pathways cannot be overstated, as it not only facilitates the exploration of a wider chemical space but also substantially increases the chances of identifying potent drug candidates that could address critical medical needs.